Barbara Ann Karmanos Cancer Institute
06/04/2026 | Press release | Archived content
IN THE NEWS – Access Health: Thoughts on ‘Stunning’ Study Presented at ASCO
June 04, 2026
Newsweek
In the June 4, 2026, edition of Newsweek's Access Health, Boris Pasche, M.D., Ph.D., FACP, president and CEO of Karmanos, commented on the results of a recent study presented at the American Society of Clinical Oncology's annual meeting. These results were of a new targeted therapy, currently pending FDA approval, that shows promise and provides hope for pancreatic cancer patients who have exhausted their first-line treatment option.
Read what Dr. Pasche had to say about the study, plus his thoughts on a study looking at the risk of obesity-related cancers for patients taking GLP-1 therapies here.
Barbara Ann Karmanos Cancer Institute published this content on June 04, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 12, 2026 at 12:10 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]